Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,643 people get AGN articles and Market Currents by email alert.
Get email alerts on AGN »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 30, 2013)
-
-
-
Business Wire (Apr 3, 2013)
-
-
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
Allergan: Earnings PreviewZacks Investment Research • Tue, May 1, 2012 -
-
Earnings Preview: AllerganTheflyonthewall • Wed, Feb 1, 2012 -
-
Allergan Beats, Revises GuidanceZacks Investment Research • Wed, Aug 3, 2011
-
-
-
-
-
Allergan: Too Late to Jump In?Derastone • Mon, Aug 9, 2010
-
Put Sellers Bet Allergan Will Hold FirmoptionMONSTER • Mon, Aug 2, 2010 -
Allergan Attracts Bearish PositionoptionMONSTER • Mon, May 3, 2010
-
Earnings Preview: AllerganTheflyonthewall • Thu, Apr 29, 2010
-
Allergan Gets FDA Approval: Botox Has a Medical Use?Ockham Research • Wed, Mar 10, 2010
-
Allergan Management Discusses Q3 2012 Results - Earnings Call TranscriptTue, Oct 30, 2012
-
Allergan Management Discusses Q3 2011 Results - Earnings Call TranscriptWed, Oct 26, 2011 • 2 Comments
-
Allergan's CEO Discusses Q1 2011 Results - Earnings Call TranscriptThu, May 5, 2011
-
Allergan's CEO Discusses Q4 2010 Results - Earnings Call TranscriptWed, Feb 2, 2011
-
Allergan CEO Discusses Q3 2010 Results - Earnings Call TranscriptMon, Nov 1, 2010
-
Allergan Q2 2010 Earnings Call TranscriptMon, Aug 2, 2010
-
Allergan Q1 2010 Earnings Call TranscriptFri, Apr 30, 2010
-
Allergan, Inc. Q4 2009 Earnings Call TranscriptThu, Feb 4, 2010
-
Allergan Q3 2009 Earnings Call TranscriptThu, Oct 29, 2009
-
Allergan Inc. Q2 2009 Earnings Call TranscriptFri, Jul 31, 2009
-
Allergan Inc. Q1 2009 Earnings Call TranscriptFri, May 1, 2009
-
Allergan Q4 2008 Earnings Call TranscriptWed, Feb 4, 2009
-
Allergan Inc. F3Q08 (Qtr End 9/30/08) Earnings Call TranscriptWed, Oct 29, 2008
-
at CNBC.com (May 2, 2013)
-
at CNBC.com (May 1, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
Business Wire (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
-
Business Wire (Apr 30, 2013)
-
at CNBC.com (Apr 26, 2013)
-
Business Wire (Apr 3, 2013)
-
at CNBC.com (Mar 26, 2013)
-
Business Wire (Feb 20, 2013)
-
at CNBC.com (Feb 6, 2013)
-
at CNBC.com (Feb 5, 2013)
-
at MarketWatch.com (Feb 5, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 31, 2013)
-
at Fox Business (Jan 23, 2013)
AGN vs. ETF Alternatives
Company Description
We are a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential — to see more clearly, move more freely and express themselves more fully. Our diversified... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, May 25, 2012, 10:10 AM Goldman recommends buying Allergan (AGN +0.2%) on its recent pullback, saying the company is well positioned with its diversified portfolio, emerging market exposure, and high growth potential. The firm reiterates its Buy rating with a $106 price target. 1 Comment [Healthcare]
- Tuesday, May 8, 2012, 3:19 AM Allergan (AGN) has received a subpoena from the Department of Health's Inspector General over Lap-Band, a gastric band that helps people lose weight. The device generated $203.1M in sales last year. Comment! [Healthcare]
- Thursday, May 3, 2012, 1:26 PM Allergan (AGN +1.5%) continues to battle back from yesterdays's 6% selloff after missing Q1 estimates, helped by positive comments out of Susquehanna this morning. The firm says AGN posted a good quarter, but wasn't surprised by the selloff and believe it's been overdone. Susquehanna says AGN adequately explained its shortcomings and expects to see growth accelerate through the remainder of the year. Worth noting: Jefferies says valuation is still rich on a relative basis, trading at around 20x estimates, versus its peers at 12x. Comment! [Healthcare, On the Move]
- Wednesday, May 2, 2012, 9:12 AM Allergan (AGN): Q1 EPS of $0.86 misses by $0.01. Revenue of $1.37B (+9.5% Y/Y) in-line. Shares -2.5% premarket. (PR) Comment! [Earnings, Healthcare, On the Move]
- Wednesday, May 2, 2012, 12:05 AM Notable earnings before Wednesday’s open: ABX, AGN, AGP, BEN, CBE, CLX, CMCSA, CVS, DVN, EPD, GRMN, HSC, HSNI, IACI, ICE, MA, MAC, MMP, MSCI, OZM, PCG, PEG, RDC, RRD, TWX, UBS, VSH Comment! [Earnings]
- Tuesday, May 1, 2012, 5:30 PM Notable earnings before Wednesday’s open: ABX, AGN, AGP, BEN, CBE, CLX, CMCSA, CVS, DVN, EPD, GRMN, HSC, HSNI, IACI, ICE, MA, MAC, MMP, MSCI, OZM, PCG, PEG, RDC, RRD, TWX, UBS, VSH 2 Comments [Earnings]
- Thursday, April 19, 2012, 5:45 PM Jim Cramer's Ultimate Growth Stocks for 2012, which boast "the kind of rapid yet consistent growth that’s coveted in an environment where economies around the globe seem to be slowing." But buy only on a pullback: AAPL, SBUX, CMG, ROST, AGN, CELG, LULU, MNST, NKE, MCD. 37 Comments [Quick Ideas]
- Monday, April 2, 2012, 12:21 PM Lazard Capital downgrades a number of names in the in the Medical Technology space today due to valuation. Intuitive Surgical (ISRG +0.2%), Endologix (ELGX -5.4%), Allergan (AGN -0.4%), St. Jude Medical (STJ -0.7%) and ZOLL Medical (ZOLL +0.1%) are all cut to Neutral. 1 Comment [Healthcare]
- Thursday, March 29, 2012, 12:48 PM Allergan (AGN +0.5%) moves up after Stifel Nicolaus raises its price target to $110 from $90 and reiterates a Buy ahead of its R&D day. The firm expects the company's newer products to generate tangible, sustainable growth. Comment! [Healthcare]
- Wednesday, March 28, 2012, 9:16 AM Allergan (AGN) reports a successful Phase III trial of its treatment for overactive bladders. The company says that based on the results it has pushed forward with applications to the FDA and EU to expand the range of patients approved for the medication. Comment! [Healthcare]
- Thursday, March 8, 2012, 10:30 AM Allergan (AGN +1.3%) saw a bounce in its Botox migraine share last month, according to Wells Fargo. The firm says research data for February shows it with an 8.8% market share among sample neurologists, up from 5.3% in January and 8.4% in December. Wells estimates U.S. sales are close to $300M annually, tracking ahead of estimates. The firm maintains its Outperform rating on the stock. Comment! [Healthcare]
- Monday, February 13, 2012, 1:54 PM Obagi Medical (OMPI +3.6%) trades higher on positive comments out of Cantor this morning. The firm says that recent data points from Allergan (AGN +1%) and Estee Lauder (EL -1.4%) support its view that the skin care products manufacturer will beat Q4 EPS estimates. Comment! [Healthcare, On the Move, Quick Ideas]
- Thursday, February 2, 2012, 9:04 AM Allergan (AGN): Q4 EPS of $1.00 in-line. Revenue of $1.38B (+7.2% Y/Y) misses by $30M. Shares -1.7% premarket. (PR) Comment! [Earnings, On the Move, Healthcare]
- Thursday, February 2, 2012, 12:05 AM Notable earnings before Thursday's open: ACM, ADS, AGN, ALKS, AZN, BCO, BSX, BX, CAH, CAM, CI, CMI, CME, DB, DO, DOW, GR, HOT, IP, K, LEA, MA, MD, MDC, MRK, MSCI, NOV, NUS, NYT, PHM, PTEN, RCL, RDEN, RGLD, ROP, SBH, SE, SLE, SNE, SXC, TE, TEN, VIAB, WBC, WEC, XEL Comment! [Earnings]
- Wednesday, February 1, 2012, 5:30 PM Notable earnings before Thursday's open: AGN, ALKS, AZN, BSX, BX, CAH,CAM, CI, CMI, DB, DO, DOW, HOT, IP, K, LEA, MA, MDC, MRK, NOV, NYT, PHM, PTEN, RCL, SBH, SE, SLE, SNE, SXC, TE, TEN, VIAB, WEC, XEL Comment! [Earnings]
- Thursday, December 1, 2011, 2:04 PM Allergan (AGN +0.8%) gets a boost from an upgrade to Buy at Argus on valuation, citing its strong growth prospects. Comment! [Healthcare, On the Move]
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in the Daily TANER Momentum [DTM] (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in the Daily TANER Momentum [DTM] (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in the Daily TANER Momentum [DTM] (my Instablog) with their security names. yk
-
- View all 5 replies
-
-
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (9/24/2012, Monday) Numbers = Term in months. The TANER Stock Model [TSM} was introduced in my <c>
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (9/13/2012, Thursday) Numbers = Term in months. The TANER Stock Model [TSM} was introduced in my <c>
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly yk
-
Michael Bryant
"Cramer thinks Allergan (AGN) and Starbucks (SBUX) represent two terrific" buys. Go with SBUX. http://yhoo.it/U8fPyL - View all 1 replies
-
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (9/11/2012, Tuesday) Numbers = Term in months. The TANER Stock Model [TSM} was introduced in my <c>
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/27/2012, Monday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
LATEST REPLIES
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (8/1/2012, Wednesday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (7/30/2012, Monday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk
-
- View all 2 replies
-
O. Young Kwon: 2 = 2-month term. Momentum can help you (a) to manage your portfolios piecemeal, not on-off fashion,<c>
-
O. Young Kwon: and (b) to decide what securities (ETFs and Stocks) to buy, sell, or hold. yk
-
- View all 3 replies
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly <c>
-
O. Young Kwon: FYI: On a vacation. Irregular postings expected. Regular postings will resume on July 29 (Sunday). yk
-
- View all 3 replies
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly <c>
-
O. Young Kwon: FYI: On a vacation. Irregular postings expected. Regular postings will resume on July 29 (Sunday). yk
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (7/11/2012, Wednesday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk.
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (7/10/2012, Tuesday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk.
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (7/9/2012, Monday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk.
-
- View all 2 replies
-
O. Young Kwon: 1 = 1-m term. T (Topping): Leading Leaders (LDLD). A (Advancing): Lagging Leaders (LGLD), <c>
-
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (626/2012, Tuesday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk.
-
Scott Matusow
I have a new article out this morning at http://seekingalpha.com/a/ec5f $OMPI $AVP $AGN $AZN $RDEA - View all 11 replies
-
-
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (6/6/2012, Wednesday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk.
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (6/5/2012, Tuesday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk.
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (6/1/2012, Friday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk.
-
- View all 2 replies
-
O. Young Kwon: SUMMARY OF STOCK TANER MOMENTUM (S.TM) (5/29/2012, Tuesday) 1,2,3 = 1-m, 2-m, 3-month term. <c>
-
O. Young Kwon: The TANER System synthesizes performances and relative strengths of 20 ETFs and 40 equities thoroughly yk.